Journey Strategic Wealth’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,257
Closed -$855K 230
2023
Q2
$855K Buy
+22,257
New +$855K 0.04% 63